N-terminal acetylated thymosin alpha-1 (Shanxi Kangbao Biological Products/Institute of Biotechnology the Academy of Military Medical Sciences PLA)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameN-terminal acetylated thymosin alpha-1 (Shanxi Kangbao Biological Products/Institute of Biotechnology the Academy of Military Medical Sciences PLA)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionThymosin receptor agonistsThymosin alpha-1 ligand
TargetsThymosin alpha-1Thymosin receptor
Therapy Area/IndicationsHepatitis CHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHepatitis CHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A